Values First Advisors, Inc. Emergent Bio Solutions Inc. Transaction History

Values First Advisors, Inc.

$181 Million
Q4 2025

A detailed history of Values First Advisors, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 305,046 shares of EBS stock, worth $3.08 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares

305,046

Previous 367,919 17.09%

Holding current value

$3.08 Million

Previous $3.25 Million 4.96%

% of portfolio

1.7%

Previous 1.82%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 30, 2026	SELL	$9.07 - $12.84 $570,258 - $807,289	-62,873 Reduced 17.09%	305,046 $3.08 Million
Q3 2025 Oct 21, 2025	SELL	$5.63 - $9.32 $45,512 - $75,342	-8,084 Reduced 2.15%	367,919 $3.25 Million
Q2 2025 Jul 29, 2025	BUY	$4.26 - $6.94 $3,220 - $5,246	756 Added 0.2%	376,003 $2.4 Million
Q1 2025 Apr 30, 2025	SELL	$4.66 - $11.66 $6,733 - $16,848	-1,445 Reduced 0.38%	375,247 $1.82 Million
Q4 2024 Jan 29, 2025	SELL	$7.72 - $11.97 $613,863 - $951,806	-79,516 Reduced 17.43%	376,692 $3.6 Million

Q3 2024 Oct 23, 2024	SELL	$5.72 - $14.77 $56,873 - $146,858	-9,943 Reduced 2.13%	456,208 $3.81 Million
Q2 2024 Jul 19, 2024	SELL	$1.86 - $6.98 $7,320 - $27,473	-3,936 Reduced 0.84%	466,151 $3.18 Million
Q1 2024 Apr 23, 2024	BUY	$1.5 - $3.41 $243,292 - $553,084	162,195 Added 52.68%	470,087 $1.19 Million
Q4 2023 Jan 18, 2024	BUY	$1.82 - $3.16 $282,451 - $490,409	155,193 Added 101.63%	307,892 $738,000
Q3 2023 Nov 08, 2023	BUY	$3.17 - $7.91 $322,693 - $805,206	101,796 Added 199.98%	152,699 $519,000
Q2 2023 Aug 02, 2023	BUY	$7.35 - $13.21 $9,422 - $16,935	1,282 Added 2.58%	50,903 $374,000
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $122,139 - $255,410	15,679 Added 46.19%	49,621 $514,000
Q4 2022 Jan 20, 2023	BUY	$11.0 - $21.45 $219,219 - $427,477	19,929 Added 142.22%	33,942 $0
Q3 2022 Dec 02, 2022	BUY	$20.09 - $35.8 $281,521 - $501,665	14,013 New	14,013 $294,000
Q2 2022 Jul 20, 2022	SELL	$27.42 - $43.63 $177,599 - $282,591	-6,477 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$36.48 - $52.22 $35,604 - $50,966	976 Added 17.74%	6,477 $266,000
Q4 2021 Mar 10, 2022	BUY	$33.11 - $55.01 $182,138 - $302,610	5,501 New	5,501 $239,000
Q2 2021 Nov 15, 2022	BUY	$56.61 - $80.46 $203,399 - $289,092	3,593 New	3,593 $226,000

Others Institutions Holding EBS

# of Institutions

195

Shares Held

41.4M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Account

Values First Advisors, Inc. Emergent Bio Solutions Inc. Transaction History